- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1993
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Biosimilar Uptake: The Importance of Healthcare Provider Education ; volume:35 ; number:4 ; day:22 ; month:8 ; year:2021 ; pages:215-224 ; date:7.2021
Pharmaceutical medicine ; 35, Heft 4 (22.8.2021), 215-224, 7.2021
- Creator
-
Oskouei, Sonia Tadjalli
Kusmierczyk, Andrew R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40290-021-00396-7
- URN
-
urn:nbn:de:101:1-2021111818075395864693
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Oskouei, Sonia Tadjalli
- Kusmierczyk, Andrew R.
- SpringerLink (Online service)
Other Objects (12)
The Importance of Countering Biosimilar Disparagement and Misinformation
Biosimilar uptake by British local formularies: a cross sectional study
Choice of healthcare provider following reform in Vietnam
Understanding healthcare provider absenteeism in Kenya: a qualitative analysis
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Impact of Value-Driven Healthcare Strategies for Biosimilar Adoption: The Singapore Story
Uptake and Competition Among Biosimilar Biological Products in the US Medicare Fee-for-Service Population
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
AVT02: An Adalimumab Biosimilar
SB8: A Bevacizumab Biosimilar
AVT04: An Ustekinumab Biosimilar
Healthcare Provider Experience in Diagnosing and Treating Cutaneous T-Cell Lymphoma
The Importance of Countering Biosimilar Disparagement and Misinformation
Biosimilar uptake by British local formularies: a cross sectional study
Choice of healthcare provider following reform in Vietnam
Understanding healthcare provider absenteeism in Kenya: a qualitative analysis
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Impact of Value-Driven Healthcare Strategies for Biosimilar Adoption: The Singapore Story
Uptake and Competition Among Biosimilar Biological Products in the US Medicare Fee-for-Service Population
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
AVT02: An Adalimumab Biosimilar
SB8: A Bevacizumab Biosimilar
AVT04: An Ustekinumab Biosimilar
Healthcare Provider Experience in Diagnosing and Treating Cutaneous T-Cell Lymphoma
The Importance of Countering Biosimilar Disparagement and Misinformation
Biosimilar uptake by British local formularies: a cross sectional study
Choice of healthcare provider following reform in Vietnam
Understanding healthcare provider absenteeism in Kenya: a qualitative analysis
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Impact of Value-Driven Healthcare Strategies for Biosimilar Adoption: The Singapore Story
Uptake and Competition Among Biosimilar Biological Products in the US Medicare Fee-for-Service Population
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
AVT02: An Adalimumab Biosimilar
SB8: A Bevacizumab Biosimilar
AVT04: An Ustekinumab Biosimilar